英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Palmitoyl Tetrapeptide-7 |
棕櫚酰四肽-7/3 |
221227-05-0 |
詳細(xì)
|
Copper Tripeptide-3 |
銅三肽-3 |
|
詳細(xì)
|
Palmitoyl Tripeptide-3 |
棕櫚酰三肽-3 |
1447824-23-8 |
詳細(xì)
|
Acetyl Tripeptide-30 Citrulline |
乙?;?30 瓜氨酸 |
2098345-00-5 |
詳細(xì)
|
Myristoyl Pentapeptide-4 |
肉豆蔻酰五肽-4/3 |
|
詳細(xì)
|
Hexapeptide-11 |
六肽-11 |
100684-36-4 |
詳細(xì)
|
Tripeptide-3 |
三肽-3 |
|
詳細(xì)
|
Acetyl Hydroxyproline |
乙?;u脯氨酸 |
33996-33-7 |
詳細(xì)
|
Acetyl Dipeptide-1 Cetyl Ester |
乙酰二肽-1 鯨蠟酯/乙酰二肽十六烷醇酯 |
196604-48-5 |
詳細(xì)
|
Dipeptide-6 |
二肽-6 |
18684-24-7 |
詳細(xì)
|
Palmitoyl Dipeptide-5 Diaminohydroxybutyrate |
棕櫚酰二肽-5 二氨基羥基丁酸酯 |
794590-34-4 |
詳細(xì)
|
Myristoyl Hexapeptide-4 |
肉豆蔻酰六肽-4 |
959610-44-7 |
詳細(xì)
|
Acetyl Tetrapeptide-2 |
乙?;碾?2 |
757942-88-4 |
詳細(xì)
|
Acetyl Tetrapeptide-40 |
乙酰基四肽-40 |
1472633-28-5 |
詳細(xì)
|
Acetyl SH-Pentapeptide-1 |
乙?;咫?1 |
97530-32-0 |
詳細(xì)
|
Acetyl Dipeptide-3 Aminohexanoate |
乙?;?3氨基己酸乙酯 |
1176133-78-0 |
詳細(xì)
|
Palmitoyl Pentapeptide-4 |
棕櫚酰五肽-4/3 |
214047-00-4 |
詳細(xì)
|
DX 600, ACE2 Inhibitor |
DX 600, ACE2 Inhibitor |
|
詳細(xì)
|
Dipeptide-1 |
二肽-1/京都啡肽/Kyotorphin |
70904-56-2 |
詳細(xì)
|
Trifluoroacetyl Tripeptide-2 |
三氟乙酰基三肽-2 |
64577-63-5 |
詳細(xì)
|
Oligopeptide-6 |
寡肽-6 |
|
詳細(xì)
|
SH-Pentapeptide-1 |
sh-五肽-1 |
|
詳細(xì)
|
Acetyl Hexapeptide-49 |
乙酰基六肽-49 |
1459205-54-9 |
詳細(xì)
|
Oligopeptide-3 |
寡肽-3 |
|
詳細(xì)
|
Angiotensin I Converting Enzyme 2, (ACE - 2) Substrate |
Mca-Ala-Pro-Lys(Dnp)-OH |
305336-82-7 |
詳細(xì)
|
Tripeptide-10 Citrulline |
三肽-10 瓜氨酸 |
960531-53-7 |
詳細(xì)
|
Hexapeptide-9 |
六肽-9 |
1228371-11-6 |
詳細(xì)
|
Palmitoyl Dipeptide-5 Diaminobutyroyl Hydroxythreonine |
棕櫚?;?5 二氨基丁酰羥基蘇氨酸 |
883558-32-5 |
詳細(xì)
|
Acetyl Tetrapeptide-15 |
乙?;碾?15 |
928007-64-1 |
詳細(xì)
|
Acetyl Hexapeptide-38 |
乙酰六肽-38 |
1400634-44-7 |
詳細(xì)
|
Decapeptide-12 |
十肽-12 |
137665-91-9 |
詳細(xì)
|
Palmitoyl Tripeptide-8 |
棕櫚酰三肽-8 |
936544-53-5 |
詳細(xì)
|
ARGININE/LYSINE POLYPEPTIDE |
精氨酸/賴氨酸多肽 |
74-79-3/56-87-1 |
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 260-274 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 215-229 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 996-1004 |
|
|
詳細(xì)
|
(Biotin - Ahx) - SARS - CoV - 2 Spike RBM (receptor binding motif) |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 |
|
|
詳細(xì)
|
Acetyl Tetrapeptide-11 |
乙?;碾?11 |
928006-88-6 |
詳細(xì)
|
Acetyl Tetrapeptide-9 |
乙酰基四肽-9 |
928006-50-2 |
詳細(xì)
|
Oligopeptide-10 |
寡肽-10 |
466691-40-7 |
詳細(xì)
|
Hexapeptide-10 |
六肽-10 |
146439-94-3 |
詳細(xì)
|
Hexapepitde-3 |
六肽-3 |
|
詳細(xì)
|
Tetrapeptide-4 |
四肽-4 |
|
詳細(xì)
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 1192-1200 |
|
|
詳細(xì)
|
SARS-CoV-2 Membrane protein, 61-70 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 322-331 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 902-917 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 1060-1068 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 352-369 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 305-319 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 647-664 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 976-984 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 125-139 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 226-234 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 1185-1193 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 329-353 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 316-324 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 891-906 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 1011-1028 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 351-358 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 305-322 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 747-763 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 958-966 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 325-339 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 40-54 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 424-433 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 329-346 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 265-274 |
|
|
詳細(xì)
|
Tetrapeptide-1 |
四肽-1 |
1632354-04-1 |
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 1220-1228 |
|
|
詳細(xì)
|
SARS-CoV-2 Membrane protein, 89-97 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 351-359 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458 |
|
|
詳細(xì)
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 - Lys(Biotin - Ahx) |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 691-699 |
|
|
詳細(xì)
|
SARS-CoV-2 Spike glycoprotein, 957-973 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 320-334 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 360-375 |
|
|
詳細(xì)
|
SARS-CoV-2 Nucleoprotein, 313-330 |
|
|
詳細(xì)
|